Annual Accounts Payable
$4.71 M
+$1.98 M+72.59%
December 31, 2023
Summary
- As of February 7, 2025, BPMC annual accounts payable is $4.71 million, with the most recent change of +$1.98 million (+72.59%) on December 31, 2023.
- During the last 3 years, BPMC annual accounts payable has risen by +$340.00 thousand (+7.78%).
- BPMC annual accounts payable is now -43.48% below its all-time high of $8.33 million, reached on December 31, 2021.
Performance
BPMC Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.72 M
-$142.00 K-2.92%
September 30, 2024
Summary
- As of February 7, 2025, BPMC quarterly accounts payable is $4.72 million, with the most recent change of -$142.00 thousand (-2.92%) on September 30, 2024.
- Over the past year, BPMC quarterly accounts payable has dropped by -$2.25 million (-32.27%).
- BPMC quarterly accounts payable is now -73.74% below its all-time high of $17.96 million, reached on March 31, 2022.
Performance
BPMC Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
BPMC Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +72.6% | -32.3% |
| 3 y3 years | +7.8% | -32.4% |
| 5 y5 years | +42.8% | -32.4% |
BPMC Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.5% | +72.6% | -73.7% | +72.8% |
| 5 y | 5-year | -43.5% | +72.6% | -73.7% | +155.3% |
| alltime | all time | -43.5% | +478.6% | -73.7% | +479.4% |
Blueprint Medicines Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.72 M(-2.9%) |
| Jun 2024 | - | $4.86 M(-1.4%) |
| Mar 2024 | - | $4.93 M(+4.6%) |
| Dec 2023 | $4.71 M(+72.6%) | $4.71 M(-32.4%) |
| Sep 2023 | - | $6.96 M(-0.2%) |
| Jun 2023 | - | $6.98 M(-33.9%) |
| Mar 2023 | - | $10.56 M(+287.1%) |
| Dec 2022 | $2.73 M(-67.3%) | $2.73 M(-35.5%) |
| Sep 2022 | - | $4.23 M(-71.9%) |
| Jun 2022 | - | $15.05 M(-16.2%) |
| Mar 2022 | - | $17.96 M(+115.5%) |
| Dec 2021 | $8.33 M(+90.7%) | $8.33 M(-12.7%) |
| Sep 2021 | - | $9.55 M(+417.0%) |
| Jun 2021 | - | $1.85 M(-36.1%) |
| Mar 2021 | - | $2.89 M(-33.9%) |
| Dec 2020 | $4.37 M(-8.8%) | $4.37 M(+49.2%) |
| Sep 2020 | - | $2.93 M(-47.6%) |
| Jun 2020 | - | $5.59 M(-34.0%) |
| Mar 2020 | - | $8.47 M(+76.7%) |
| Dec 2019 | $4.79 M | $4.79 M(+117.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $2.20 M(-66.7%) |
| Jun 2019 | - | $6.61 M(+49.5%) |
| Mar 2019 | - | $4.42 M(+34.1%) |
| Dec 2018 | $3.30 M(-11.9%) | $3.30 M(-17.3%) |
| Sep 2018 | - | $3.99 M(+33.8%) |
| Jun 2018 | - | $2.98 M(-9.4%) |
| Mar 2018 | - | $3.29 M(-12.2%) |
| Dec 2017 | $3.74 M(+69.3%) | $3.74 M(+79.0%) |
| Sep 2017 | - | $2.09 M(-18.9%) |
| Jun 2017 | - | $2.58 M(+13.1%) |
| Mar 2017 | - | $2.28 M(+3.2%) |
| Dec 2016 | $2.21 M(-9.9%) | $2.21 M(+19.6%) |
| Sep 2016 | - | $1.85 M(-32.3%) |
| Jun 2016 | - | $2.73 M(-1.6%) |
| Mar 2016 | - | $2.77 M(+13.0%) |
| Dec 2015 | $2.46 M(+201.6%) | $2.46 M(+57.2%) |
| Sep 2015 | - | $1.56 M(-3.0%) |
| Jun 2015 | - | $1.61 M(-31.0%) |
| Mar 2015 | - | $2.33 M(+186.7%) |
| Dec 2014 | $814.00 K(-42.4%) | $814.00 K |
| Dec 2013 | $1.41 M | - |
FAQ
- What is Blueprint Medicines annual accounts payable?
- What is the all time high annual accounts payable for Blueprint Medicines?
- What is Blueprint Medicines annual accounts payable year-on-year change?
- What is Blueprint Medicines quarterly accounts payable?
- What is the all time high quarterly accounts payable for Blueprint Medicines?
- What is Blueprint Medicines quarterly accounts payable year-on-year change?
What is Blueprint Medicines annual accounts payable?
The current annual accounts payable of BPMC is $4.71 M
What is the all time high annual accounts payable for Blueprint Medicines?
Blueprint Medicines all-time high annual accounts payable is $8.33 M
What is Blueprint Medicines annual accounts payable year-on-year change?
Over the past year, BPMC annual accounts payable has changed by +$1.98 M (+72.59%)
What is Blueprint Medicines quarterly accounts payable?
The current quarterly accounts payable of BPMC is $4.72 M
What is the all time high quarterly accounts payable for Blueprint Medicines?
Blueprint Medicines all-time high quarterly accounts payable is $17.96 M
What is Blueprint Medicines quarterly accounts payable year-on-year change?
Over the past year, BPMC quarterly accounts payable has changed by -$2.25 M (-32.27%)